(2-Chloropyridin-3-yl)boronic acid → [7-(2-Chloro-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-yl]-(4-morpholin-4-yl-phenyl)-amine

HRID 1262190Notes

Reaction equation

HRID 1262190 reaction equation
Br[C:2]1[N:10]2[C:5]([CH:6]=[N:7][C:8]([NH:11][C:12]3[CH:17]=[CH:16][C:15]([N:18]4[CH2:23][CH2:22][O:21][CH2:20][CH2:19]4)=[CH:14][CH:13]=3)=[N:9]2)=[CH:4][CH:3]=1.[Cl:24][C:25]1[C:30](B(O)O)=[CH:29][CH:28]=[CH:27][N:26]=1>>[Cl:24][C:25]1[C:30]([C:2]2[N:10]3[C:5]([CH:6]=[N:7][C:8]([NH:11][C:12]4[CH:13]=[CH:14][C:15]([N:18]5[CH2:23][CH2:22][O:21][CH2:20][CH2:19]5)=[CH:16][CH:17]=4)=[N:9]3)=[CH:4][CH:3]=2)=[CH:29][CH:28]=[CH:27][N:26]=1

Participants

3

Procedure

[7-(2-Chloro-pyridin-3-yl)-pyrrolo[2,1-f][1,2,4]triazin-2-yl]-(4-morpholin-4-yl-phenyl)-amine was prepared from (7-bromo-pyrrolo[2,1-f][1,2,4]triazin-2-yl)-(4-morpholin-4-yl-phenyl)-amine and 2-chloro-3-pyridineboronic acid in an analogous manner to Example 1031b. Product isolated as a yellow foam (48 mg, 40%). LCMS (m/e) 407 (M+H); 1H-NMR (CDCl3, 400 MHz) δ 8.74 (s, 1H), 8.50-8.44 (m, 1H), 8.23 (d, 1H, J=7.6 Hz), 7.43 (d, 2H, J=7.8 Hz), 7.41-7.34 (m, 1H), 7.10-7.05 (m, 1H), 6.88-6.80 (m, 3H), 6.67 (s, 1H), 3.91-3.82 (m, 4H), 3.13-3.06 (m, 4H).

Sources & evidence

ORD record
ord-5434cf4413ad466c9e72028797ad8d8d
Source dataset
uspto-grants-2013_06
Patent number
US08471005B2

Reaction notes

Loading…